Triangel is dedicated to providing superior medical solutions for healthcare and aesthetic professionals worldwide. Driven by innovative technology and clinical evidence, Triangel continuously explores “better medical solutions.”
RegenOS™ Global Launch: A New Era of Regenerative Medicine from Cell Activation to Tissue Remodeling in 20 Days
Four Wavelengths, Multi-Target Synergistic Regeneration
RegenOS™ is not simply an upgrade to traditional laser equipment, but a complete regenerative strategy system. The platform integrates
Triangel’s mature dual-wavelength surgical technology (980nm + 1470nm) with innovative regenerative biomodulation wavelengths (638nm + 658nm), enabling physicians to precisely target different biological levels within a single system—from superficial cell stimulation to deep tissue remodeling.
Specifically:
638nm / 658nm acts on mitochondria, initiating photobiological regulation mechanisms to promote cell activation and proliferation;
980nm / 1470nm achieves high-precision cutting and deep tissue thermal modulation, providing a structural basis for tissue remodeling.
20 Days: From Clinical Validation to Patient Perception
RegenOS™‘s “20-day return on investment” concept is not just marketing rhetoric, but based on actual clinical observations: from cell activation and tissue remodeling to initial structural regeneration, the entire process can achieve key transformations within 20 days. For medical aesthetic institutions, this translates to shorter patient wait times, higher treatment turnover rates, and greater patient satisfaction.
Multidisciplinary Applications · One Device, Limitless Possibilities
The platform has demonstrated broad adaptability in the following areas:
Regenerative Aesthetics (Skin Rejuvenation, Scar Repair)
Minimally Invasive Surgery (Soft Tissue Cutting, Coagulation)
Pain Management and Rehabilitation Medicine
Oral and Otolaryngological Soft Tissue Treatment
“RegenOS™ is a truly multidisciplinary platform that frees physicians from the limitations of a single tool, allowing them to freely select wavelengths, modes, and energy parameters based on the patient’s different tissue conditions.”
Tailor-Made for High-End Medical Aesthetic Institutions
In addition to its technological advantages, RegenOS™ also boasts high appeal in clinical operations:
High Patient Comfort: Non-invasive or minimally invasive experience
Broad Range of Indications: Covering both aesthetic and therapeutic needs
High Return on Investment: Rapid recovery of equipment costs
Combination Therapy-Friendly Design: Seamless integration with other medical aesthetic or surgical solutions
Looking to the Future
The launch of RegenOS™ marks a new stage in regenerative medicine, moving from “single repair” to “procedural, multi-wavelength, and structure-oriented” approaches. Triangel stated that they will continue to focus on real-world clinical needs, promoting the implementation and standardization of regenerative platforms across more disciplines.
Post time: Apr-15-2026